In alignment with declines in hepatic steatosis, we also found that 17α-E2 treatment robustly downregulated hepatic SCD1 protein in male WT, but not ERβKO, mice (Fig. 5A,B), which is congruent with our prior report46. This evidence concerns the gene SCD and Hepatic steatosis.